Li-Yao Huang

Cancer Researcher | CRISPR • Genome Engineering | Oxford DPhil • Founder

FinalDose· Spring 2026🇬🇧 Oxford, England, United Kingdom

in LinkedIn

2026Chief Scientific Officer· FinalDose

In tech · since 2020

Company

FinalDose

Role

Chief Scientific Officer

current

Stage

—

no public source

Raised

—

no public source

Based

Oxford, England, United Kingdom

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

FinalDose

Programmable DNA drug destroying all cancers, unlocking 80% of targets

Spring 2026

Experience

Career

FinalDose
Chief Scientific Officer · Oxford, England, United Kingdom · 2026 – Present
2026
MRC Weatherall Institute of Molecular Medicine
Postdoctoral Researcher · Oxford, England, United Kingdom · 2020 – 2025
2020
The Department of Biochemistry, University of Oxford
Postdoctoral Researcher · Oxford, England, United Kingdom · 2020
2020

Bio

Founder at FinalDose (YC P26). DPhil in Biochemistry from Oxford, where he spent 5 years as a postdoctoral researcher at the MRC Weatherall Institute of Molecular Medicine. Led CRISPR screening projects uncovering new druggable targets in cancer cells and built pipelines reducing hit validation time from months to 7 days. Research focuses on BRCA1-deficient cancers and PARP inhibitor resistance mechanisms.